Full Coverage

Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in Chronic Constipation and Irritable...

yahoo.com
Apr 7, 2008
        
Story Timeline:  229 days

NEW YORK----Callisto Pharmaceuticals, Inc. announced today that through its wholly-owned subsidiary, Synergy Pharmaceuticals, Inc. it filed an IND on April 2, 2008 with the FDA for SP-304 for the treatment of chronic constipation and constipation-predominant irritable bowel syndrome. [read full story]                    

Add Comment
Latest article on this story:

Callisto Pharmaceuticals Files IND For SP-304 (Guanilib) In Chronic Constipation And Irritable...

 medicalnewstoday.com Apr 10, 2008
First article on this story:

Callisto Pharmaceuticals Files IND for SP-304 (Guanilib) in Chronic Constipation and Irritable Bow..

 euroinvestor.co.uk Apr 7, 2008
Selected publications with coverage of this story:
medicalnewstoday.com yahoo.com euroinvestor.co.uk pharmiweb.co.uk
RELATED
Found 1 documents:

Callisto Pharmaceuticals Files IND For SP-304 (Guanilib) In Chronic Constipation And Irritable...

medicalnewstoday.com
Apr 10, 2008
        

Callisto Pharmaceuticals, Inc. (AMEX: KAL; FWB: CA4) announced that through its wholly-owned subsidiary, Synergy Pharmaceuticals, Inc. it filed an IND on April 2, 2008 with the FDA for SP-304 (also called Guanilib) for the treatment of chronic constipation and constipation-predominant irritable...